Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia

It was recently recognized that some chronic myeloid leukemia patients with a complete molecular response could sustain that response after discontinuation of imatinib. To characterize the clinical outcomes and profiles of chronic phase chronic myeloid leukemia patients who could discontinue imatini...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Takahashi, Naoto, Kyo, Taiichi, Maeda, Yasuhiro, Sugihara, Takashi, Usuki, Kensuke, Kawaguchi, Tatsuya, Usui, Noriko, Okamoto, Shinichiro, Ohe, Yokiko, Ohtake, Shigeki, Kitamura, Kunio, Yamamoto, Masahide, Teshima, Hirofumi, Motoji, Toshiko, Tamaki, Toshiharu, Sawada, Kenichi, Ohyashiki, Kazuma
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2012
Témata:
Original Articles and Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3366657/
https://ncbi.nlm.nih.gov/pubmed/22180435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.056853
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky